K

KeyMed Biosciences Inc
HKEX:2162

Watchlist Manager
KeyMed Biosciences Inc
HKEX:2162
Watchlist
Price: 32.6 HKD -0.91% Market Closed
Market Cap: 9.1B HKD
Have any thoughts about
KeyMed Biosciences Inc?
Write Note

Wall Street
Price Targets

Price Targets Summary
KeyMed Biosciences Inc

Wall Street analysts forecast KeyMed Biosciences Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KeyMed Biosciences Inc is 60.93 HKD with a low forecast of 50.5 HKD and a high forecast of 75.6 HKD.

Lowest
Price Target
50.5 HKD
55% Upside
Average
Price Target
60.93 HKD
87% Upside
Highest
Price Target
75.6 HKD
132% Upside
KeyMed Biosciences Inc Competitors:
Price Targets
VRTX
Vertex Pharmaceuticals Inc
33% Upside
BIIB
Biogen Inc
74% Upside
SRZN
Surrozen Inc
219% Upside
CNTB
Connect Biopharma Holdings Ltd
651% Upside
EXAS
Exact Sciences Corp
24% Upside
ALRN
Aileron Therapeutics Inc
658% Upside
TLX
Telix Pharmaceuticals Ltd
8% Upside
NRIX
Nurix Therapeutics Inc
65% Upside

Revenue
Forecast

Revenue Estimate
KeyMed Biosciences Inc

The compound annual growth rate of KeyMed Biosciences Inc's revenue for the next 4 years is 56%.

N/A
Past Growth
56%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
KeyMed Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
29%
Average Beat

Net Income
Forecast

Net Income Estimate
KeyMed Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
21%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KeyMed Biosciences Inc's stock price target?
Price Target
60.93 HKD

According to Wall Street analysts, the average 1-year price target for KeyMed Biosciences Inc is 60.93 HKD with a low forecast of 50.5 HKD and a high forecast of 75.6 HKD.

What is KeyMed Biosciences Inc's Revenue forecast?
Projected CAGR
56%

The compound annual growth rate of KeyMed Biosciences Inc's revenue for the next 4 years is 56%.

Back to Top